About Moles, Melanomas, and Lasers: The Dermatologist's Schizophrenic Attitude Toward Pigmented Lesions [1]

Archives of Dermatology

Volumn 139, Issue 11, 2003, Pages 1405-1406

  Dummer, Reinhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DACARBAZINE; PEGINTERFERON ALPHA2A; RECOMBINANT ALPHA INTERFERON; RECOMBINANT INTERFERON;

ABDOMINAL METASTASIS; ANAMNESIS; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER REGRESSION; CANCER RISK; CANCER SURGERY; CAUSE OF DEATH; CLINICAL FEATURE; CLINICAL TRIAL; DENDRITIC CELL; DERMATOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; HEALTH EDUCATION; HISTOPATHOLOGY; HUMAN; LENTIGO; LETTER; LOW LEVEL LASER THERAPY; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MALIGNANT LENTIGO; MEDICAL SPECIALIST; MELANOMA; METASTASIS; NEVUS; PLASTIC SURGERY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN BIOPSY; SKIN CANCER; SKIN METASTASIS; VACCINATION;

DERMATOLOGY; DIAGNOSTIC ERRORS; HUMANS; LASER SURGERY; MELANOMA; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 0242408763     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.11.1405     Document Type: Letter

References (15)

1. Heinzerling LM, Dummer R, Panizzon RG, Bloch PH, Barbezat R, Burg G. Prevention campaign against skin cancer. Dermatology. 2002;205:229-233.
2. Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol. 2001;14:280-290.
3. Brochez L, Naeyaert JM. Understanding the trends in melanoma incidence and mortality: where do we stand? Eur J Dermatol. 2000;10:71-75.
4. Marks R. Epidemiology of melanoma. Clin Exp Dermatol. 2000;25:459-463.
5. Hauschild A, Garbe C, Stolz W, et al. Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). Br J Cancer. 2001;84:1036-1042.
6. Nestle F, Burg G, Dummer R. New perspectives on immunobiology and immunotherapy of melanoma. Immunol Today. 1999;20:5-7.
7. Böni R, Boni RA, Steinert H, et al. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose. Br J Dermatol. 1995;132:556-562.
8. Heinzerling L, Dummer R, Wildberger H, Burg G. Cutaneous ulceration after injection of polyethylene-glycol-modified interferon alpha associated with visual disturbances in a melanoma patient. Dermatology. 2000;201:154-157.
9. Böer A, Wolter M, Kaufmann R. Pseudomelanom nach Lasertherapie oder lasertherapiertes Melanom? J Dtsch Dermatol Ges. 2003;1:47-50.
10. Grob M, Senti G, Dummer R. Diagnoseverzögerung bei einem amelanotischen Melanom durch CO2-Laserung. Schweiz Rundsch Med Prax. 1999;88:1491-1494.
11. Dummer R, Kempf W, Burg G. Pseudo-melanoma after laser therapy. Dermatology. 1998;197:71-73.
12. Trau H, Orenstein A, Schewach Miller M, Tsur H. Pseudomelanoma following laser therapy for congenital nevus. J Dermatol Surg Oncol. 1986;12:984-986.
13. Ueda S, Imayama S. Normal-mode ruby laser for treating congenital nevi. Arch Dermatol. 1997;133:355-359.
14. Vibhagool C, Byers HR, Grevelink JM. Treatment of small nevomelanocytic nevi with a Q-switched ruby laser. J Am Acad Dermatol. 1997;36:738-741.
15. Dummer R, Bosch U, Panizzon R, Bloch PH, Burg G. Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology. 2001;203:75-80.